RETURN TO WORK WITH CONFIDENCE. SPEAK TO US TO SEE HOW WE CAN SUPPORT YOU. READ OUR COVID-19 POLICY here.

Oxford Brain Diagnostics awarded £1.4m to test technology in NHS

May 17th 2021
Interviews are conducted by The Oxford Trust to give insight into the science and tech businesses they support in their innovation centres: the Oxford Centre for Innovation and the Wood Centre for Innovation.
Based in our Oxford Centre for Innovation, Oxford Brain Diagnostics (OBD) wins £1.4m funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostics in the NHS.

A spinout from the University of Oxford, Oxford Brain Diagnostics, run by Dr Steven Change (see photo above), is a software company focused on developing diagnostics based on changes in the brain at cellular level. The project will assess Cortical Disarray Measurement, or CDM, as a tool to diagnose mild cognitive impairment due to Alzheimer’s disease. The grant highlights the critical need for continued investment in the UK for dementia and to explore breakthrough technologies that can support improved diagnostics. The CDM software device was awarded Breakthrough Device designation by the FDA in August 2020.

Alzeheimer’s remains a complex condition so examining MRI scan data from the NHS at the earliest stages of the disease provides a valuable opportunity to estimate patient progress, assess the future economic impact patients will have in long-term care, provide valuable time for families to adjust, and get access to new drug treatments

The multi-centre project is led by Oxford Brain Diagnostics but includes the University of Oxford Health Economics Research Centre, University Hospital Southampton NHS Foundation Trust, NIHR community Healthcare MedTech and IVD Cooperative Cardif & the Vale University Health Board, Cardiff, Southampton, South Wales universities and Bournemouth University Institute of Medical Imaging and Visualisation.

For more information on Oxford Brain Diagnostics, see here  Follow the links to find out more about the Oxford Centre for Innovation and its sister site the Wood Centre for Innovation.

October 18th 2021

Five minutes with Huw Price, Managing Director of Curiosity Software

Five minutes with Huw Price, Managing Director of Curiosity Software

September 8th 2021

Further government funding supports phase II R&D lab conversion at The Oxford Trust’s Wood Centre for Innovation

The Oxford Trust, the local charity encouraging the pursuit of science and enterprise, is to commence the second phase of its conversion of dedicated high spec laboratory facilities at its Wood Centre for Innovation in Headington, Oxford, following £0.2 million additional Local Growth Fund support, secured by the Oxfordshire Local Enterprise Partnership (OxLEP).

August 19th 2021

Client company Optellum announces strategic collaboration with Johnson & Johnson

Optellum, a lung-health AI company based at our Oxford Centre for Innovation, has just announced a strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson. Through the collaboration, Optellum will use its AI-powered clinical decision support platform to increase lung cancer survival rates through early intervention and prevention.